Adrian Hill | Director and Professor
The Jenner Institute - University of Oxford

Professor Sir Adrian Hill founded The Jenner Institute at the University of in 2005, one of the largest academic vaccine centres globally with vaccine programmes against fifteen diseases. The Institute focuses on designing and developing vaccines for diseases prevalent in developing countries such as HIV/AIDS, malaria and tuberculosis.   He is a Fellow of the Royal Society, the UK Academy of Medical Sciences, the Royal College of Physicians and a Knight Commander of the Order of the British Empire (KBE).   He is a passionate believer in the power of molecular medicine to design and deliver new healthcare interventions to improve the lives of the least wealthy in sub-Saharan Africa and elsewhere in the world. In 2014 his group led the first clinical trial of an Ebola virus vaccine targeting the outbreak in West Africa. He was a co-leader of the research team which produced the Oxford-AstraZeneca COVID-19 vaccine, over 3bn doses of which have been distributed to over 180 countries and saved an estimated 6.2 million lives in 2021 alone.  The R21 Matrix-M malaria vaccine, which recently achieved WHO prequalification, was designed and made in his laboratory and he is the chief investigator of the R21/Matrix-M clinical trial programme.